IRIS
MISSALE, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.093
AS - Asia 7.558
EU - Europa 4.424
SA - Sud America 1.173
AF - Africa 440
Continente sconosciuto - Info sul continente non disponibili 312
OC - Oceania 16
Totale 22.016
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.839
SG - Singapore 2.777
CN - Cina 1.736
VN - Vietnam 1.134
IT - Italia 1.097
BR - Brasile 911
IE - Irlanda 828
SE - Svezia 669
HK - Hong Kong 581
BD - Bangladesh 410
DE - Germania 399
FR - Francia 382
ZA - Sudafrica 295
NL - Olanda 233
FI - Finlandia 209
TR - Turchia 205
IN - India 151
CA - Canada 146
GB - Regno Unito 119
RU - Federazione Russa 112
AR - Argentina 100
UA - Ucraina 80
KR - Corea 74
JP - Giappone 67
AT - Austria 65
IQ - Iraq 65
MX - Messico 56
ID - Indonesia 44
PH - Filippine 40
CI - Costa d'Avorio 39
CO - Colombia 38
PL - Polonia 36
PK - Pakistan 35
VE - Venezuela 33
BE - Belgio 32
EC - Ecuador 29
ES - Italia 28
UZ - Uzbekistan 28
TH - Thailandia 24
CZ - Repubblica Ceca 22
KE - Kenya 22
MA - Marocco 22
MY - Malesia 20
TW - Taiwan 19
CL - Cile 18
PY - Paraguay 18
LT - Lituania 17
AE - Emirati Arabi Uniti 14
AU - Australia 13
AZ - Azerbaigian 12
EG - Egitto 12
GR - Grecia 12
JO - Giordania 11
RO - Romania 11
SA - Arabia Saudita 11
UY - Uruguay 11
IL - Israele 10
OM - Oman 10
PE - Perù 10
IR - Iran 9
JM - Giamaica 9
KZ - Kazakistan 9
CR - Costa Rica 8
DK - Danimarca 8
PS - Palestinian Territory 8
TN - Tunisia 8
AL - Albania 7
BY - Bielorussia 7
CH - Svizzera 7
DZ - Algeria 7
KH - Cambogia 7
NP - Nepal 7
BG - Bulgaria 6
LV - Lettonia 6
PA - Panama 6
AM - Armenia 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
EU - Europa 5
GE - Georgia 5
GT - Guatemala 5
KG - Kirghizistan 5
LU - Lussemburgo 5
RS - Serbia 5
AO - Angola 4
BO - Bolivia 4
HN - Honduras 4
LB - Libano 4
LY - Libia 4
PT - Portogallo 4
QA - Qatar 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
BH - Bahrain 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
MN - Mongolia 3
NI - Nicaragua 3
SI - Slovenia 3
Totale 21.662
Salva come PNG Salva come JPEG
Città #
Singapore 1.423
Ashburn 1.040
San Jose 842
Dublin 828
Chandler 620
Santa Clara 602
Dallas 569
Hong Kong 542
Beijing 403
Ho Chi Minh City 324
Council Bluffs 321
Hanoi 293
Johannesburg 274
Boardman 269
Parma 240
New York 232
Los Angeles 216
Ann Arbor 201
Dearborn 191
Shanghai 176
Lauterbourg 156
Princeton 147
Izmir 132
Nanjing 120
Munich 116
Milan 104
Wilmington 99
São Paulo 98
Hefei 88
Grafing 77
Helsinki 74
Buffalo 73
Jacksonville 73
Rome 66
Columbus 65
Moscow 59
Jinan 55
Seoul 54
Haiphong 53
Tokyo 53
Shenyang 51
Vienna 51
Des Moines 50
Chicago 49
Da Nang 49
Toronto 47
Seattle 44
Bologna 43
Bremen 43
Frankfurt am Main 41
Abidjan 39
Tianjin 37
Montreal 36
The Dalles 36
Turku 36
Bengaluru 34
Rio de Janeiro 34
Guangzhou 32
Hebei 32
Kunming 31
Nuremberg 31
Kocaeli 30
Warsaw 30
London 28
Nanchang 28
Naples 26
Orem 26
Phoenix 26
Brooklyn 25
Reggio Emilia 25
Stockholm 25
Brussels 24
Changsha 24
Jakarta 24
Redmond 23
Tashkent 23
Ardea 22
Houston 22
Jiaxing 21
Mexico City 21
Zhengzhou 21
Belo Horizonte 20
Amsterdam 19
Atlanta 19
Chennai 19
Denver 19
Dhaka 19
Boston 18
Hải Dương 18
Nairobi 18
Norwalk 18
San Mateo 18
Baghdad 17
Hangzhou 17
Salvador 17
Düsseldorf 16
Istanbul 16
San Francisco 16
Fairfield 15
Fremont 15
Totale 13.042
Salva come PNG Salva come JPEG
Nome #
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 329
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 324
Role of immunoglobulin G fragment C receptor polymorphism-mediatedantibody-dependant1. cellular cytotoxicity in colorectal cancer treated withcetuximab therapy. Pharmacogenomics J. 300
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 284
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B 257
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 223
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 222
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 221
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 214
A simplified sars-cov-2 pseudovirus neutralization assay 213
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus 208
L-Asparaginase and Inhibitors of Glutamine Synthetase DiscloseGlutamine Addiction of Beta-Catenin-Mutated Human HepatocellularCarcinoma Cells 202
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 188
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 187
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 183
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 181
Metabolic regulation of the HBV-specific T cell function 180
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 179
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells (Frontiers in Oncology, (2022), 12, (942341), 10.3389/fonc.2022.942341) 174
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 172
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 162
1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients 160
Resolution of late-onset heart and liver failures after reversion of jejuno-ileal bypass: a case report 160
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 160
[68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors 159
Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature 158
Correlation between LDH levels and response to sorafenib in HCC patients: An analysis of the ITA.LI.CA database 158
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy 158
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 158
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma 157
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter 157
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 156
Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation 156
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 156
Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation 155
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 153
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use 153
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. 151
HBV immune-therapy: From molecular mechanisms to clinical applications 150
Immune gene expression profile in hepatocellular carcinoma and surrounding tissue predicts time to tumor recurrence 149
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 148
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients 146
T cell regulation in HBV-related chronic liver disease 146
Ex vivo characterization of tumor-derived melanoma antigenencoding gene-specific CD8 1 cells in patientswith hepatocellular carcinoma 144
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 143
[Surgical risks for cirrhotic patients] 143
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts 142
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 140
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection 139
Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab 139
Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient 139
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study 139
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 137
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 137
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines 137
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment 136
The changing scenario of hepatocellular carcinoma in Italy: an update 136
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 136
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 134
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 134
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 133
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 130
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. 128
Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes 127
Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu-Positive Metastatic Breast Cancer. 127
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 125
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma. 125
AISF position paper on HCV in immunocompromised patients 124
Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma 123
Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics 122
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 122
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 122
Head-injured subjects aged over 50 years: correlations between variables of trauma and neuropsychologial follow-up 121
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab 120
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 119
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 119
Rise and fall of HCV-related hepatocellular carcinoma in Italy: A long-term survey from the ITA.LI.CA centres 117
COMPOSTO E COMPOSIZIONE PER IL RIPRISTINO METABOLICO E FUNZIONALE DEI LINFOCITI NK NELL’EPATOCARCINOMA E RELATIVO METODO 116
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 116
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro 116
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen 115
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 115
Fine specificity of the human T cell response to hepatitis B virus core antigen 114
Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/NEU-positive metastatic breast cancer 113
Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial 111
Metabolic disorders across hepatocellular carcinoma in Italy 111
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma 111
Etanercept in the treatment of psoriasis and psoriathic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients 111
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 111
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 110
Comparative pathogenesis of HBV and HCV 110
Immune pathogenesis of hepatitis B 108
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 108
Monofocal hepatocellular carcinoma: How much does size matter? 108
The surgical risk in cirrhosis of the liver 108
Oral lichen planus infiltrating T-cells:a Pathogenetic role for HCV-specific T cell responses? 107
In reply 107
Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections 106
Combination of radiofrequency ablation and immunotherapy 106
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor 104
Totale 15.008
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022708 0 21 26 53 47 91 38 54 36 21 44 277
2022/20232.802 318 250 185 172 168 298 53 157 988 25 116 72
2023/20241.260 72 122 42 57 113 292 85 88 46 74 92 177
2024/20254.417 91 221 279 233 492 548 224 198 576 421 361 773
2025/20269.865 830 877 1.142 850 1.268 489 1.017 311 1.248 743 690 400
2026/2027587 262 325 0 0 0 0 0 0 0 0 0 0
Totale 22.016